Global Program Head, Neurology Development

Job Title: Global Program Head, Neurology Development

Location: Cambridge, MA

About the Job

Are you ready to shape the future of medicine? The race is on to speed up drug discovery and development to find answers for patients and their families. Your skills could be critical in helping our teams accelerate progress.

We are an innovative global healthcare company with one purpose: to chase the miracles of science to improve people’s lives. We’re also a company where you can flourish and grow your career, with countless opportunities to explore, make connections with people, and stretch the limits of what you thought was possible. Ready to get started?

The Neurology Development Global Program Head (GPH) is a key position that oversees mainly early development activities in the Neurology & Ophthalmology Development (NOD) and is responsible for shaping strategy as well as managing execution. This is a highly visible role that will work closely with the Research and Development Heads in the Therapeutic Area to build and expand the early portfolio in Neurology.  Unlike other GPH roles, this role is focused on multiple projects from IND-enabling studies to first in human studies and successful proof of concept trials. New programs come from the internal research pipeline and from in-licensing. The Early Development GPH is a critical contributor for the selection of projects to move forward and will drive execution of projects until they have achieved proof of concept. In some cases, the GPH may transition lead a later stage global program team (GPT).

At Sanofi we chase the miracles of science. Sanofi believes that the more we understand about disease pathogenesis in the human nervous system, the greater the chance we can produce life-changing therapies. Over the next five years, Sanofi plans to test in the clinic potentially disease-modifying treatments for disease such as Multiple Sclerosis (MS), Chronic Inflammatory Demyelinating Polyradiculopathy (CIDP), Alzheimer's Disease (ALZ), Parkinson’s Disease (PD), Amyotrophic Lateral Sclerosis (ALS), as well as other CNS diseases.

Scientific excellence, integrative thinking and strong interpersonal skills will be required to succeed in this role. The Neurology Development GPH reports to the TA Head, NOD. The impact on the organization is extensive due to the ability to influence disease area strategy, and the network of collaborators from preclinical research to operational, regulatory and commercial functions.

Success in this role requires the ability to influence and lead at the highest possible level. The Neurology Development GPH will be a critical member of the NOD leadership team and will be joining at a key point in time with the opportunity to build and influence group. This role will require the ability to innovate and think creatively, engage multiple internal and external stakeholders, and make key decisions.

The GPH position requires achieving results through others and supporting the senior management team in achieving corporate goals. The GPH establishes the goals for the global project team (GPT) and participates in strategic planning for, and oversight of, the clinical and research activities of his/her area of responsibility. The GPH will be delegated such responsibilities as interaction with regulatory/health authorities, approval of protocols, informed consent documents, clinical study reports and product label. In addition, the GPH will be responsible for the communication strategy and scientific disclosures and travel authorizations, expense reports, and will interact with opinion leaders and consultants.

Sanofi‘s specialty care is mainly focused on four Therapeutic Areas: Rare and Rare Blood Diseases, Neurology & Ophthalmology Development (NOD), Immunology, and Oncology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.

The NOD includes programs in Multiple Sclerosis, Neuroimmunology, Neurodegeneration, and Ophthalmology, with therapeutic modalities encompassing Small Molecules, Biologics, and Gene Therapy.  Sanofi has a large internal research team in addition to the Genomic Medicine Unit (GMU), which are committed to building the future pipeline in various neurological and ophthalmological diseases.

Main Responsibilities:

Scientific and technical Expertise

• Has and maintains deep scientific, technical and clinical